Locally advanced and metastatic gastric cancer: current management and new treatment developments.
about
A novel peptide (GX1) homing to gastric cancer vasculature inhibits angiogenesis and cooperates with TNF alpha in anti-tumor therapyPhase I study of imatinib, cisplatin and 5-fluoruracil or capecitabine in advanced esophageal and gastric adenocarcinoma.Signet ring cell carcinoma of the stomach is significantly associated with poor prognosis and diffuse gastric cancer (Lauren's): single-center experience of 160 cases.Treatment options in patients with metastatic gastric cancer: current status and future perspectivesPlatinum-based versus non-platinum-based chemotherapy as first line treatment of inoperable, advanced gastric adenocarcinoma: a meta-analysis.Vertebral carcinomatosis eleven years after advanced gastric cancer resection: A case reportEvaluation of a novel functional single-nucleotide polymorphism (rs35010275 G>C) in MIR196A2 promoter region as a risk factor of gastric cancer in a Chinese population.What lurks beneath: IL-11, via Stat3, promotes inflammation-associated gastric tumorigenesis.Correlation between chemosensitivity to anticancer drugs and telomerase reverse transcriptase mRNA expression in gastric cancerOncogenic pathway combinations predict clinical prognosis in gastric cancer.Gastric cancer pharmacogenetics: progress or old tripe?Ramucirumab: targeting angiogenesis in the treatment of gastric cancer.Angiogenesis inhibitors in gastric and gastroesophageal junction cancer.Calycosin Enhances Some Chemotherapeutic Drugs Inhibition of Akt Signaling Pathway in Gastric Cells.Pharmacogenetic angiogenesis profiling for first-line chemotherapy in patients with advanced gastric cancer.Prognostic significance of p53 protein expression in early gastric cancer.Trastuzumab in HER2-positive metastatic gastric cancer: profile report.An assessment of candidate genes to assist prognosis in gastric cancer.
P2860
Q33501372-5C1E0E91-2F13-43C2-875D-3982663A43AAQ34507843-12EA3333-5FC0-499F-837C-BFA2EE28E187Q34634206-E0F5CA5F-F51A-4A06-AA97-3135E78F5C78Q34661367-259A1BAF-AA0F-426F-94AB-EBB640AD6B1FQ34852173-B774FA2F-CFB6-4022-BD09-55A345D9C347Q35042311-97B7E439-4E9E-4149-9259-14B7E0C10CE1Q36193792-5C92EED3-591A-4757-8608-D8B74CD5CC4EQ36570500-05DBE223-290A-4C3A-8312-82C3BF782019Q36688969-F5400225-8E16-42DD-91B3-3D1989A52BB7Q37357165-BFF82A5B-D661-4184-8F75-CE3521889370Q38120288-2AD54BF1-7F62-43A1-905C-A7D2AC9CEF0CQ38286373-2B5E3DDB-7710-4191-A411-43839E15F6E7Q38578404-90F9F1B1-E67D-462C-85F9-4E422FA494D9Q38709260-964067FD-9E8E-41F2-9127-475FB59F778FQ46538043-29B4E7F0-6C2A-4C4E-8D12-6B9B8D0CF284Q53286581-ED5C5DD5-3374-42C7-9A9D-DB54A38B6235Q54569855-E66FF706-B2F3-4CCF-9BD3-959E9FC97A13Q55080792-2C9433B6-FBE5-44F8-A849-C59551C666A1
P2860
Locally advanced and metastatic gastric cancer: current management and new treatment developments.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Locally advanced and metastati ...... nd new treatment developments.
@en
Locally advanced and metastati ...... nd new treatment developments.
@nl
type
label
Locally advanced and metastati ...... nd new treatment developments.
@en
Locally advanced and metastati ...... nd new treatment developments.
@nl
prefLabel
Locally advanced and metastati ...... nd new treatment developments.
@en
Locally advanced and metastati ...... nd new treatment developments.
@nl
P2093
P1433
P1476
Locally advanced and metastati ...... nd new treatment developments.
@en
P2093
Kathryn Field
Michael Michael
Trevor Leong
P304
P356
10.2165/00003495-200868030-00004
P577
2008-01-01T00:00:00Z